Bausch + Lomb Corporation announced the appointment of Eduardo C. Alfonso, MD, and Steven H. Collis to its board of directors.
The appointments are effective Jan. 1, 2026, expanding the board to 10 directors.
These appointments are a significant strategic move towards shaping the future of Bausch + Lomb.
Expert Appointments
Dr. Eduardo C. Alfonso, a renowned ophthalmologist, and Steven H. Collis, a seasoned industry leader, join as board members.
Experience and Expertise
Alfonso brings expertise in corneal diseases, while Collis has a strong background in pharmaceuticals and healthcare services.
Strategic Vision
Their appointment reflects Bausch + Lomb's focus on accelerating strategy and capitalizing on future growth opportunities.
- The addition of Dr. Alfonso and Collis to the board signifies a commitment to leveraging diverse talents and experience for the company's growth.
- Their insights and industry knowledge are expected to contribute significantly to driving Bausch + Lomb's vision forward.
The new board appointments at Bausch + Lomb mark a pivotal moment in the company's journey towards enhancing its leadership and strategic direction.